2021 Revenues ($USD) : $4,718,000,000
2021 R&D spend : na
2021 Number of Employees : na
Fiscal Year End : 12/31/2021
Leader : CEO Robert B. Ford

After it spun off AbbVie in 2013, Abbott continued to focus on selling off-patent medicines. The established pharmaceuticals division has a significant presence in India, Vietnam, Pakistan, Latin America and South America. In all, Abbott’s Established Pharmaceutical Products serves more than 100 countries. In 2021, the pharmaceutical division generated $4.718 billion in revenue, close to 11% of the firm’s total. —BB